Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Advances in Therapy|March 31, 2010
Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringeOnur Baser, Jonathan Bouchard, Tony DeLuzio, et al.Current Medical Research and Opinion|September 4, 2012
Assessing achievement and maintenance of glycemic control by patients initiating basal insulinNing Wu, Mark Aagren, Luke Boulanger, et al.Current Medical Research and Opinion|November 26, 2005
Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucomaStefan Holmstrom, Patricia Buchholz, John Walt, et al.Current Medical Research and Opinion|March 23, 2021
Real-world evidence costs of allergic rhinitis and allergy immunotherapy in the commercially insured United States populationJoseph P Tkacz, Karen Rance, Douglas Waddell, et al.Pharmacology|August 6, 2008
Indirect comparison of once daily insulin detemir and glargine in reducing weight gain and hypoglycaemic episodes when administered in addition to conventional oral anti-diabetic therapy in patients with type-2 diabetesWalid Fakhoury, Ian Lockhart, Robert W Kotchie, et al.Journal of Medical Economics|March 31, 2010
Cost-effectiveness of switching to biphasic insulin aspart from human premix insulin in a US settingJames L Palmer, Martin S Knudsen, Mark Aagren, et al.Journal for Specialists in Pediatric Nursing : JSPN|February 8, 2011
Human growth hormone treatment: synthesis of literature on product delivery systems and administration practicesMonali Bhosle, David Klingman, Mark Aagren, et al.Clinical Therapeutics|March 15, 2011
Concurrent control of blood glucose, body mass, and blood pressure in patients with type 2 diabetes: an analysis of data from electronic medical recordsCarrie McAdam-Marx, Jonathan Bouchard, Mark Aagren, et al.Current Medical Research and Opinion|November 19, 2009
Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulinCarrie McAdam-Marx, Junhua Yu, Jonathan Bouchard, et al.Scandinavian Journal of Public Health|August 7, 2010
Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in SwedenWilliam J Valentine, Mark Aagren, Mattias Haglund, et al.Pageof 4